📰 Adrenoleukodystrophy News
Adrenoleukodystrophy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adrenoleukodystrophy. Real-time updates on events, politics, business and more.
July 3, 2024
And coming up on bbc news arsenal drop points in the race for the Premier League title after losing to aston villa. They are now two points behind manchester city. Good afternoon. Israels war cabinet is meeting now to discuss options for retaliation against iran after its drone and Missile Attacks on saturday night. Israel says 99 of the iranian weapons were safely intercepted. One senior israeli minister says his country will exact a price on iran for the attack when the timing is right. But Wo...
February 3, 2024
Babies born in Hawaii will now be screened for two more genetic disorders. They are Spinal Muscular Atrophy (SMA) and Adrenoleukodystrophy (A-XLD).
March 29, 2023
The state where a baby is born determines what serious and rare disorders he or she will be screened for shortly after birth. It’s a patchwork of policies across the country that could have dire consequences. Some parents call it death by ZIP code.
March 27, 2023
The state where a baby is born determines what serious and rare disorders he or she will be screened for shortly after birth. It’s a patchwork of policies across the country that could have dire consequences. Some parents call it death by ZIP code.
December 22, 2022
For a boy with a rare disease, a nonprofit’s monthly visits are vital. But compassion extends beyond the simple task of food delivery.
October 13, 2022
Here are the shortcomings I saw in the phase II Relyvrio study
August 12, 2022
The family of a young Savannah boy hopes a bone marrow transplant will stop a deadly disease that could rob him of his vision, hearing and even his life.
June 10, 2022
Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors
May 17, 2022
POXEL SA (Euronext: POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic
February 16, 2022
Phase 2a clinical Proof-of-Concept biomarker study for PXL065 in adrenoleukodystrophy (ALD) now anticipated to start midyear, with results to follow in early 2023 POXEL SA (Euronext: POXEL FR0012432516)